dc.contributor.author
Carola, Giulia
dc.contributor.author
Malagarriga, Daniel
dc.contributor.author
Calatayud Aristoy, Carles
dc.contributor.author
Pons-Espinal, Meritxell
dc.contributor.author
Blasco Agell, Lucas
dc.contributor.author
Richaud-Patin, Yvonne
dc.contributor.author
Fernandez-Carasa, Irene
dc.contributor.author
Baruffi, Valentina
dc.contributor.author
Beltramone, Silvia
dc.contributor.author
Molina, Elsa
dc.contributor.author
Dell’Era, Patrizia
dc.contributor.author
Toledo Aral, Juan J.
dc.contributor.author
Tolosa, Eduardo
dc.contributor.author
Muotri, Alysson R.
dc.contributor.author
Garcia Ojalvo, Jordi
dc.contributor.author
Soriano i Fradera, Jordi
dc.contributor.author
Raya Chamorro, Ángel
dc.contributor.author
Consiglio, Antonella
dc.date.issued
2021-07-19T08:21:12Z
dc.date.issued
2021-07-19T08:21:12Z
dc.date.issued
2021-07-02
dc.date.issued
2021-07-16T07:19:47Z
dc.identifier
https://hdl.handle.net/2445/179150
dc.description.abstract
A deeper understanding of early disease mechanisms occurring in Parkinson's disease (PD) is needed to reveal restorative targets. Here we report that human induced pluripotent stem cell (iPSC)-derived dopaminergic neurons (DAn) obtained from healthy individuals or patients harboring LRRK2 PD-causing mutation can create highly complex networks with evident signs of functional maturation over time. Compared to control neuronal networks, LRRK2 PD patients' networks displayed an elevated bursting behavior, in the absence of neurodegeneration. By combining functional calcium imaging, biophysical modeling, and DAn-lineage tracing, we found a decrease in DAn neurite density that triggered overall functional alterations in PD neuronal networks. Our data implicate early dysfunction as a prime focus that may contribute to the initiation of downstream degenerative pathways preceding DAn loss in PD, highlighting a potential window of opportunity for pre-symptomatic assessment of chronic degenerative diseases.
dc.format
application/pdf
dc.relation
Reproducció del document publicat a: https://doi.org/10.1038/s41531-021-00198-3
dc.relation
npj Parkinson's Disease, 2021, vol. 7, num. 55
dc.relation
https://doi.org/10.1038/s41531-021-00198-3
dc.relation
info:eu-repo/grantAgreement/EC/H2020/713140/EU//MESO_BRAIN
dc.rights
cc by (c) Carola, Giulia et al., 2021
dc.rights
http://creativecommons.org/licenses/by/3.0/es/
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Patologia i Terapèutica Experimental)
dc.subject
Malaltia de Parkinson
dc.subject
Mutació (Biologia)
dc.subject
Enginyeria genètica
dc.subject
Parkinson's disease
dc.subject
Mutation (Biology)
dc.subject
Genetic engineering
dc.title
Parkinson’s disease patient-specific neuronal networks carrying the LRRK2 G2019S mutation unveil early functional alterations that predate neurodegeneration
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion